These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38190619)

  • 1. Impact of Insulin Sensitivity and β-Cell Function Over Time on Glycemic Outcomes in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE): Differential Treatment Effects of Dual Therapy.
    Utzschneider KM; Younes N; Butera NM; Balasubramanyam A; Bergenstal RM; Barzilay J; DeSouza C; DeFronzo RA; Elasy T; Krakoff J; Kahn SE; Rasouli N; Valencia WM; Sivitz WI;
    Diabetes Care; 2024 Apr; 47(4):571-579. PubMed ID: 38190619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal Effects of Glucose-Lowering Medications on β-Cell Responses and Insulin Sensitivity in Type 2 Diabetes: The GRADE Randomized Clinical Trial.
    Rasouli N; Younes N; Ghosh A; Albu J; Cohen RM; DeFronzo RA; Diaz E; Sayyed Kassem L; Luchsinger JA; McGill JB; Sivitz WI; Tamborlane WV; Utzschneider KM; Kahn SE;
    Diabetes Care; 2024 Apr; 47(4):580-588. PubMed ID: 38211595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycemia Reduction in Type 2 Diabetes - Glycemic Outcomes.
    ; Nathan DM; Lachin JM; Balasubramanyam A; Burch HB; Buse JB; Butera NM; Cohen RM; Crandall JP; Kahn SE; Krause-Steinrauf H; Larkin ME; Rasouli N; Tiktin M; Wexler DJ; Younes N
    N Engl J Med; 2022 Sep; 387(12):1063-1074. PubMed ID: 36129996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emulating the GRADE trial using real world data: retrospective comparative effectiveness study.
    Deng Y; Polley EC; Wallach JD; Dhruva SS; Herrin J; Quinto K; Gandotra C; Crown W; Noseworthy P; Yao X; Lyon TD; Shah ND; Ross JS; McCoy RG
    BMJ; 2022 Oct; 379():e070717. PubMed ID: 36191949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Effects of Glucose-Lowering Medications on Kidney Outcomes in Type 2 Diabetes: The GRADE Randomized Clinical Trial.
    Wexler DJ; de Boer IH; Ghosh A; Younes N; Bebu I; Inzucchi SE; McGill JB; Mudaliar S; Schade D; Steffes MW; Tamborlane WV; Tan MH; Ismail-Beigi F;
    JAMA Intern Med; 2023 Jul; 183(7):705-714. PubMed ID: 37213109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety over 26 weeks of an oral treatment strategy including sitagliptin compared with an injectable treatment strategy with liraglutide in patients with type 2 diabetes mellitus inadequately controlled on metformin: a randomised clinical trial.
    Charbonnel B; Steinberg H; Eymard E; Xu L; Thakkar P; Prabhu V; Davies MJ; Engel SS
    Diabetologia; 2013 Jul; 56(7):1503-11. PubMed ID: 23604551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential Effects of Type 2 Diabetes Treatment Regimens on Diabetes Distress and Depressive Symptoms in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE).
    Gonzalez JS; Bebu I; Krause-Steinrauf H; Hoogendoorn CJ; Crespo-Ramos G; Presley C; Naik AD; Kuo S; Johnson ML; Wexler D; Crandall JP; Bantle AE; Arends V; Cherrington AL;
    Diabetes Care; 2024 Apr; 47(4):610-619. PubMed ID: 38416773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Effects of Randomized Second-line Therapy for Type 2 Diabetes on a Composite Outcome Incorporating Glycemic Control, Body Weight, and Hypoglycemia: An Analysis of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE).
    Kirkman MS; Tripputi M; Krause-Steinrauf H; Bebu I; AbouAssi H; Burch H; Duran-Valdez E; Florez H; Garvey WT; Hsia DS; Salam M; Pop-Busui R;
    Diabetes Care; 2024 Apr; 47(4):594-602. PubMed ID: 38194519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Baseline Factors With Glycemic Outcomes in GRADE: A Comparative Effectiveness Randomized Clinical Trial.
    Garvey WT; Cohen RM; Butera NM; Kazemi EJ; Younes N; Rosin SP; Suratt CE; Ahmann A; Hollander PA; Krakoff J; Martin CL; Seaquist E; Steffes MW; Lachin JM;
    Diabetes Care; 2024 Apr; 47(4):562-570. PubMed ID: 38285957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of liraglutide versus sitagliptin, both in combination with metformin, in Chinese patients with type 2 diabetes: a 26-week, open-label, randomized, active comparator clinical trial.
    Zang L; Liu Y; Geng J; Luo Y; Bian F; Lv X; Yang J; Liu J; Peng Y; Li Y; Sun Y; Bosch-Traberg H; Mu Y
    Diabetes Obes Metab; 2016 Aug; 18(8):803-11. PubMed ID: 27060930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fixed-Dose Combination of Dapagliflozin + Sitagliptin + Metformin in Patients with Type 2 Diabetes Poorly Controlled with Metformin: Phase 3, Randomized Comparison with Dual Combinations.
    Sahay RK; Giri R; Shembalkar JV; Gupta SK; Mohan B; Kurmi P; Kumar SR; Sawardekar VM; Mishra A; Murthy LS; Arya VV; Sonawane AR; Soni PN; Gofne SK; Karnawat SR; Rajurkar MN; Patel PM; Lakhwani LK; Mehta SC; Joglekar SJ
    Adv Ther; 2023 Jul; 40(7):3227-3246. PubMed ID: 37258803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of sitagliptin/metformin fixed-dose combination compared with glimepiride in patients with type 2 diabetes: A multicenter randomized double-blind study.
    Kim SS; Kim IJ; Lee KJ; Park JH; Kim YI; Lee YS; Chung SC; Lee SJ
    J Diabetes; 2017 Apr; 9(4):412-422. PubMed ID: 27229178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline Characteristics of Randomized Participants in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE).
    Wexler DJ; Krause-Steinrauf H; Crandall JP; Florez HJ; Hox SH; Kuhn A; Sood A; Underkofler C; Aroda VR;
    Diabetes Care; 2019 Nov; 42(11):2098-2107. PubMed ID: 31391203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of the effects of a dipeptidyl peptidase-IV inhibitor and sulfonylurea on glucose variability in patients with type 2 diabetes with inadequate glycemic control on metformin.
    Kim HS; Shin JA; Lee SH; Kim ES; Cho JH; Son HY; Yoon KH
    Diabetes Technol Ther; 2013 Oct; 15(10):810-6. PubMed ID: 24050737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycemia Reduction in Type 2 Diabetes - Microvascular and Cardiovascular Outcomes.
    ; Nathan DM; Lachin JM; Bebu I; Burch HB; Buse JB; Cherrington AL; Fortmann SP; Green JB; Kahn SE; Kirkman MS; Krause-Steinrauf H; Larkin ME; Phillips LS; Pop-Busui R; Steffes M; Tiktin M; Tripputi M; Wexler DJ; Younes N
    N Engl J Med; 2022 Sep; 387(12):1075-1088. PubMed ID: 36129997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HARMONY 3: 104-week randomized, double-blind, placebo- and active-controlled trial assessing the efficacy and safety of albiglutide compared with placebo, sitagliptin, and glimepiride in patients with type 2 diabetes taking metformin.
    Ahrén B; Johnson SL; Stewart M; Cirkel DT; Yang F; Perry C; Feinglos MN;
    Diabetes Care; 2014 Aug; 37(8):2141-8. PubMed ID: 24898304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of Metformin in the GRADE Cohort: Effect on Glycemia and Body Weight.
    Sivitz WI; Phillips LS; Wexler DJ; Fortmann SP; Camp AW; Tiktin M; Perez M; Craig J; Hollander PA; Cherrington A; Aroda VR; Tan MH; Krakoff J; Rasouli N; Butera NM; Younes N;
    Diabetes Care; 2020 May; 43(5):940-947. PubMed ID: 32139384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Use of Rescue Insulin in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE).
    Hollander PA; Krause-Steinrauf H; Butera NM; Kazemi EJ; Ahmann AJ; Fattaleh BN; Johnson ML; Killean T; Lagari VS; Larkin ME; Legowski EA; Rasouli N; Willis HJ; Martin CL;
    Diabetes Care; 2024 Apr; 47(4):638-645. PubMed ID: 37756542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between baseline characteristics and clinical outcomes in a large population of diabetes patients treated with liraglutide in a real-world setting in Italy.
    Lapolla A; Frison V; Bettio M; Dal Pos M; Rocchini P; Panebianco G; Tadiotto F; Da Tos V; D'Ambrosio M; Marangoni A; Ferrari M; Pianta A; Balzano S; Confortin L; Lamonica M; Marin N; Strazzabosco M; Brun E; Mesturino CA; Simoncini M; Zen F; Bax G; Bonsembiante B; Cardone C; Dal Frà MG; Gallo A; Masin M; Piarulli F; Sartore G; Simioni N
    Clin Ther; 2015 Mar; 37(3):574-84. PubMed ID: 25626486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic efficacy and safety of initial triple combination of metformin, sitagliptin, and lobeglitazone in drug-naïve patients with type 2 diabetes: initial triple study.
    Lim S; Ku EJ; Lee SY; Lee JH; Lee JE; Kim KM; Davies MJ
    BMJ Open Diabetes Res Care; 2020 Jan; 8(1):. PubMed ID: 31958303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.